Any feedback?
Literature summary for 1.1.3.8 extracted from
- Restoration of vitamin C synthesis in transgenic Gulo-/- mice by helper-dependent adenovirus-based expression of gulonolactone oxidase (2008), Hum. Gene Ther., 19, 1349-1357.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | a gene therapy approach can be successfully employed in the treatment and further study of vitamin C deficiency in scurvy-prone mammals | Mus musculus |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Mus musculus | P58710 | - |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| GULO | - |
Mus musculus |
| gulonolactone oxidase | - |
Mus musculus |
General Information
| General Information | Comment | Organism |
|---|---|---|
| malfunction | a deficiency in GULO expression results in the inability to produce vitamin C. Using a previously derived Gulo-expressing vector, which produces murine GULO under the control of the murine cytomegalovirus (mCMV) promoter, a recombinant helper-dependent adenovirus (HDAd-mCMV-Gulo) is constructed that can be used to correct this genetic defect. A human liver cell line (Hep G2) infected with the HDAd-mCMV-Gulo vector expresses GULO in a time- and gene dose-dependent manner. These cells also produce ascorbic acid when exogenous gulonolactone is supplemented in the medium. Likewise, Gulo(-/-) mice treated with HDAd-mCMV-Gulo express GULO in the liver and produce ascorbic acid | Mus musculus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
